BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20939399)

  • 1. [Hepatitis D: forgotten but not gone].
    Moradpour D; Negro F
    Rev Med Suisse; 2010 Sep; 6(261):1656-9. PubMed ID: 20939399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis D: A Review.
    Negro F; Lok AS
    JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis D revival.
    Wedemeyer H
    Liver Int; 2011 Jan; 31 Suppl 1():140-4. PubMed ID: 21205152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The return of the hepatitis delta virus].
    Zoutendijk R; de Jonge PJ; de Man RA
    Ned Tijdschr Geneeskd; 2016; 160():D70. PubMed ID: 27405575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of delta hepatitis.
    Gunsar F
    Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis delta: virological and clinical aspects.
    Botelho-Souza LF; Vasconcelos MPA; Dos Santos AO; Salcedo JMV; Vieira DS
    Virol J; 2017 Sep; 14(1):177. PubMed ID: 28903779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis delta virus.
    Hughes SA; Wedemeyer H; Harrison PM
    Lancet; 2011 Jul; 378(9785):73-85. PubMed ID: 21511329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
    Mansour W; Ducancelle A; Le Gal F; Le Guillou-Guillemette H; Abgueguen P; Pivert A; Calès P; Gordien E; Lunel F
    J Clin Virol; 2010 Jan; 47(1):97-9. PubMed ID: 19914127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
    Grabowski J; Yurdaydìn C; Zachou K; Buggisch P; Hofmann WP; Jaroszewicz J; Schlaphoff V; Manns MP; Cornberg M; Wedemeyer H;
    Liver Int; 2011 Oct; 31(9):1395-405. PubMed ID: 21762356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
    Ferrante ND; Lo Re V
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.
    Castelnau C; Le Gal F; Ripault MP; Gordien E; Martinot-Peignoux M; Boyer N; Pham BN; Maylin S; Bedossa P; Dény P; Marcellin P; Gault E
    Hepatology; 2006 Sep; 44(3):728-35. PubMed ID: 16941695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and patient characteristics of hepatitis D virus infection in the West of Scotland 2011-2016.
    Jackson C; Gunson RN; Bradley-Stewart A; Bennett S; Black H; Kennedy N; Bell DJ
    J Viral Hepat; 2018 Nov; 25(11):1395-1396. PubMed ID: 29851188
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis: antiviral treatment for hepatitis D.
    Triantos C; Kalafateli M; Nikolopoulou V; Burroughs A
    Aliment Pharmacol Ther; 2012 Mar; 35(6):663-73. PubMed ID: 22273482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of and New Therapies for Hepatitis D.
    Koh C; Heller T; Glenn JS
    Gastroenterology; 2019 Jan; 156(2):461-476.e1. PubMed ID: 30342879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis delta: immunopathogenesis and clinical challenges.
    Grabowski J; Wedemeyer H
    Dig Dis; 2010; 28(1):133-8. PubMed ID: 20460901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis D.
    Husa P; Linhartová A; Nemecek V; Husová L
    Acta Virol; 2005; 49(4):219-25. PubMed ID: 16402678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.